文献速递类风湿关节炎脊柱关节炎

产后对类风湿关节炎与脊柱关节炎患者疾病活动的影响:GR2前瞻性队列辅助分析

Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort.
PubMed 文献 · RMD Open · 2026-04-28

该研究基于法国GR2前瞻性队列,纳入94例类风湿关节炎(RA)和124例脊柱关节炎(SpA)孕妇,描述产后疾病活动、治疗及母乳喂养率。RA患者在产后前6个月出现至少一次发作的比例显著高于妊娠期(62.0% vs 43.5%;p=0.02),而SpA患者产后6个月疾病活动与妊娠期无差异(40.7% vs 40.7%;p=0.999)。母乳喂养状态与产后疾病活动无关,约半数未使用DMARD分娩的患者在产后重启bDMARD。

要点

  • RA患者产后前6个月发作比例显著高于妊娠期(62.0% vs 43.5%;p=0.02)。
  • SpA患者产后6个月疾病活动与妊娠期无差异(40.7% vs 40.7%;p=0.999)。
  • 母乳喂养状态与RA或SpA产后疾病活动无差异。

核心结论

  • RA患者产后早期更易发作,而SpA患者产后疾病活动保持稳定。
  • SpA患者妊娠期持续使用bDMARD的比例高于RA患者,约半数患者产后重启bDMARD。

研究设计与样本

  • 共纳入94例RA和124例SpA患者,描述疾病活动、发作、治疗及母乳喂养率,采用生存分析评估发作相关因素。

主要发现

  • RA患者产后前6个月至少一次发作的比例为62.0%,妊娠期为43.5%(p=0.02)。
  • SpA患者产后6个月疾病活动比例为40.7%,与妊娠期40.7%无差异(p=0.999)。
  • RA和SpA患者产后疾病活动在不同母乳喂养状态(从未、<6个月、≥6个月)间相似。
  • 13/91(14.3%)RA患者和29/123(23.6%)SpA患者在 entire pregnancy and postpartum 持续使用bDMARD。
  • 78/91例RA和94/123例SpA患者分娩时未使用任何DMARD,其中43/78(55.1%)和56/94(59.6%)产后重启bDMARD。

临床怎么用

  • RA患者产后早期应加强疾病活动监测,警惕发作风险。
  • SpA患者产后疾病活动可能保持稳定,但仍需个体化评估。
  • 母乳喂养状态不影响产后疾病活动,不应作为限制母乳喂养的依据。
  • 妊娠期未使用DMARD分娩的患者,约半数产后需重启bDMARD,应提前规划治疗。

局限性

  • 原文未报告局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe disease activity and treatments received during the postpartum period, breastfeeding rates and their possible impact on rheumatoid arthritis (RA) and spondyloarthritis (SpA) activity. METHOD: This ancillary study from the French multicentre prospective cohort (GR2-NCT02450396) included pregnant women with RA and SpA with at least one postpartum visit from October 2014 to October 2022. Disease activity, flares, treatments and breastfeeding rates were described. Factors associated with the occurrence of a flare were evaluated by survival analysis. Disease activity was compared according to breastfeeding duration (never, <6 months and ≥6 months). RESULTS: Ninety-four RA and 124 SpA patients were studied. In RA patients, the proportion of patients presenting with at least one flare was significantly higher during the first 6 months postpartum compared with pregnancy (62.0% vs 43.5%; p=0.02). For SpA patients, there was no difference in disease activity at 6 months postpartum compared with pregnancy (40.7% vs 40.7%; p=0.999). Disease activity in postpartum was similar between the different breastfeeding status in both diseases. 13/91 (14.3%) RA patients and 29/123 (23.6%) SpA patients continued a biologic Disease-Modifying Antirheumatic Drug (bDMARD) during the whole pregnancy and the postpartum. 78/91 RA and 94/123 SpA patients delivered without any DMARDs, and among them, 43/78 (55.1%) and 56/94 (59.6%) (re)started a bDMARD postpartum. CONCLUSION: RA patients were more likely to flare during early postpartum, while SpA patients remained stable. bDMARD continuation during pregnancy was more frequent in SpA patients, and half of the patients restarted bDMARD during postpartum.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Hornez M, Molto A, Leroy M, et al. Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort. RMD Open. 2026. PMID: 42049394. doi:10.1136/rmdopen-2025-006593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。